These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26989680)

  • 21. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
    Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
    Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
    Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
    Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
    J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Head and neck cancer--Part 2: Treatment and prognostic factors.
    Mehanna H; West CM; Nutting C; Paleri V
    BMJ; 2010 Sep; 341():c4690. PubMed ID: 20876637
    [No Abstract]   [Full Text] [Related]  

  • 25. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
    Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
    Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
    Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based analysis of prognostic indicators in sebaceous carcinoma of the head and neck.
    Thomas WW; Fritsch VA; Lentsch EJ
    Laryngoscope; 2013 Sep; 123(9):2165-9. PubMed ID: 23670399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple primary melanomas versus single melanoma of the head and neck: a comparison of genetic, diagnostic, and therapeutic implications.
    Pollio A; Tomasi A; Pellacani G; Ruini C; Mandel VD; Fortuna G; Seidenari S; Ponti G
    Melanoma Res; 2014 Jun; 24(3):267-72. PubMed ID: 24638154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [What makes "Head-and-Neck-Cancers" recur: Tumorinvasion "revisited"].
    Simon C; Koitschev A; Plinkert PK
    Laryngorhinootologie; 2007 Mar; 86(3):172-5. PubMed ID: 17351878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.
    Graveland AP; Golusinski PJ; Buijze M; Douma R; Sons N; Kuik DJ; Bloemena E; Leemans CR; Brakenhoff RH; Braakhuis BJ
    Int J Cancer; 2011 Apr; 128(8):1852-9. PubMed ID: 20568113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 32. [Molecular biology studies of late recurrence of testicular cancers].
    Albers P; Honecker F; Rüschoff J; Sauter G; Müller SC; Büttner R; Bokemeyer C
    Urologe A; 2007 Sep; 46(9):1185-6. PubMed ID: 17646956
    [No Abstract]   [Full Text] [Related]  

  • 33. Personalizing cancer care: updates on head and neck cancer.
    de Souza JA; Cohen EE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
    Maula SM; Luukkaa M; Grénman R; Jackson D; Jalkanen S; Ristamäki R
    Cancer Res; 2003 Apr; 63(8):1920-6. PubMed ID: 12702584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
    Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
    Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity of chromosome 9p21 and 7q31 is correlated with high incidence of recurrent tumor in head and neck squamous cell carcinoma.
    Matsuura K; Shiga K; Yokoyama J; Saijo S; Miyagi T; Takasaka T
    Anticancer Res; 1998; 18(1A):453-8. PubMed ID: 9568119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spindle cell lesions: A review on immunohistochemical markers.
    ; Metgud R; Naik S; Patel S
    J Cancer Res Ther; 2017; 13(3):412-418. PubMed ID: 28862201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Field cancerisation in the head and neck.
    Ogden GR
    Oral Dis; 1998 Mar; 4(1):1-3. PubMed ID: 9655036
    [No Abstract]   [Full Text] [Related]  

  • 39. All that glitters is not gold: Clinical implications from the genetic analysis of head and neck cancer recurrences.
    Gallo O; Locatello LG
    Oral Oncol; 2021 Jun; 117():105187. PubMed ID: 33582000
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic markers of head and neck cancer: identifying new molecular targets.
    Bradford CR
    Arch Otolaryngol Head Neck Surg; 2003 Mar; 129(3):366-7. PubMed ID: 12622552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.